Headline
The latest stories from AHA Today.
“Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping patients navigate that process,” writes Ari Levin, AHA’s director of coverage policy.
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Maine, Minnesota, New Mexico and Washington, D.C., to extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and Children’s Health Insurance Program enrollees under the American…
COVID-19 hospitalization rates are about 50% higher for adults eligible for Medicare because of a disability than for other adults enrolled in Medicare.
President Biden yesterday directed the Health and Human Services Secretary to develop and release sample policies for states “to safeguard and expand access to health care for LGBTQI+ individuals and their families, including mental health services.”
A Food and Drug Administration advisory committee today recommended the agency authorize Moderna’s COVID-19 two-dose vaccine for children aged 6 months through 5 years old and Pfizer’s three-dose COVID-19 vaccine for children aged 6 months through 4 years old
The National Center for Healthcare Leadership is accepting nominations through July 8 for the 2022 Gail L. Warden Leadership Excellence Award.
The Food and Drug Administration Friday authorized the first COVID-19 test to identify and differentiate certain SARS-CoV-2 lineages in respiratory samples that test positive for the virus.
The Centers for Disease Control and Prevention yesterday updated its guidance to help clinicians evaluate and test patients with relevant history, signs and symptoms for monkeypox
The Senate Health, Education, Labor & Pensions Committee last night voted 13-9 to advance legislation that would reauthorize Food and Drug Administration user fee programs and modify the regulatory framework for laboratory developed tests
The U.S. Supreme Court today ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program, and…